Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/25/24 20:54 | 9/23/24 | LGND | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | FL | O | CLO,Secr | 4 | M.d | 542 | 77.39 | 0 | 7 | 45 | 23 | D | ||||||||||||||
9/25/24 20:54 | 9/23/24 | LGND | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | FL | O | CLO,Secr | 4 | S.d | -542 | 77.39 | 0 | -7 | 23 | D | |||||||||||||||
9/24/24 19:41 | 9/20/24 | LGND | Health | Drug | Pharmaceutical Preparations | Espinoza Octavio | FL | O | CFO | 3 | S.d | -301 | 85.64 | 0 | -4 | 26 | D | |||||||||||||||
9/24/24 19:41 | 9/20/24 | LGND | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | FL | O | P,COO | 4 | M.dm | 4,731 | 85.34 | 0 | 55 | 52 | D | |||||||||||||||
9/24/24 19:41 | 9/20/24 | LGND | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | FL | O | P,COO | 4 | S.dm | -4,731 | 85.34 | 0 | -55 | 52 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |